Showing results (1-10 of 100) with videos related to
Sort By:
Pageof 10
Biological & Pharmaceutical Bulletin|January 7, 2020
Steroid-Resistant Asthma and NeutrophilsTakeshi NabeJournal of Pharmacological Sciences|September 13, 2014
Interleukin (IL)-33: new therapeutic target for atopic diseasesTakeshi NabeNihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|September 1, 2022
[Pathogenic changes in group 2 innate lymphoid cells (ILC2) in intractable asthma]Takeshi NabeNihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|July 2, 2025
[Roles of extracellular vesicles in allergen-specific immunotherapy]Masaya Matsuda, Takeshi NabeYakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|December 2, 2021
[Anti-inflammatory Strategies by Focusing on the Particularity of Ocular Immunity]Takeshi Nabe, Masaya MatsudaBiological & Pharmaceutical Bulletin|December 5, 2012
Exposure to multiwalled carbon nanotubes and allergen promotes early- and late-phase increases in airway resistance in miceNobuaki Mizutani, Takeshi Nabe, Shin YoshinoImmunology|January 18, 2013
Interleukin-33 and alveolar macrophages contribute to the mechanisms underlying the exacerbation of IgE-mediated airway inflammation and remodelling in miceNobuaki Mizutani, Takeshi Nabe, Shin YoshinoMethods in Molecular Biology (Clifton, N.J.)|November 23, 2020
Diet-Induced Mouse Model of Atopic DermatitisMasanori Fujii, Yuki Shimazaki, Takeshi NabeEuropean Journal of Pharmacology|August 19, 2003
Augmentation of spontaneous cough by enalapril through up-regulation of bradykinin B1 receptors in guinea pigsRikiya Hirata, Takeshi Nabe, Shigekatsu KohnoJournal of Immunology (Baltimore, Md. : 1950)|August 18, 2009
Complement C3a regulates late asthmatic response and airway hyperresponsiveness in miceNobuaki Mizutani, Takeshi Nabe, Shin YoshinoPageof 10